Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Hengkang Pharmaceutical is a specialized pharmaceutical manufacturer based in Xianju, Zhejiang Province, China. The company focuses on the development and production of high-quality Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates, with a strong emphasis on cardiovascular and antiviral therapeutic areas. Their core product portfolio includes widely used statins such as Atorvastatin, Rosuvastatin, and Pitavastatin, as well as the antiviral drug Entecavir. Zhejiang Hengkang operates state-of-the-art manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards, enabling them to export products to global markets. In addition to its own product line, the company provides contract development and manufacturing organization (CDMO) services to international pharmaceutical partners. By leveraging advanced chemical synthesis technologies, Zhejiang Hengkang has established itself as a reliable supplier in the global pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Hengkang Pharm Group.